|National Journal of Medical Research|
GUIDE FOR AUTHORS
manuscript will be reviewed for possible publication with the
understanding that it is being submitted to NJMR alone at that point in
time and has not been published anywhere, simultaneously submitted, or
already accepted for publication elsewhere. The journal expects that
authors would authorize one of them to correspond with the Journal for
all matters related to the manuscript.
manuscripts received are duly acknowledged. On submission, editors
review all submitted manuscripts initially for suitability for formal
that are found suitable for publication in NJMR are sent to two or more
expert reviewers. During submission, the contributor is requested to
provide names of two or three qualified reviewers who have had
experience in the subject of the submitted manuscript, but this is not
mandatory. The reviewers should not be affiliated with the same
institutes as the contributor/s. However, the selection of these
reviewers is at the sole discretion of the editor.
journal follows a double-blind review process, wherein the reviewers
and authors are unaware of each others’ identity. Every manuscript is
also assigned to a member of the editorial team, who based on the
comments from the reviewers takes a final decision on the manuscript.
comments and suggestions (acceptance/ rejection/ amendments in
manuscript) received from reviewers are conveyed to the corresponding
author. If required, the author is requested to provide a point by point
response to reviewers’ comments and submit a revised version of the
manuscript. This process is repeated till reviewers and editors are
satisfied with the manuscript.
accepted for publication are copy edited for grammar, punctuation,
print style, and format. The whole process of submission of the
manuscript to final decision and sending and receiving proofs is
completed online. To achieve faster and greater dissemination of
knowledge and information, the journal will try to publish articles
online as Ahead of Print immediately on acceptance.
Conflicts of Interest/ Competing Interests
All authors of
must disclose any and all conflicts of interest they may have with
publication of the manuscript or an institution or product that is
mentioned in the manuscript and/or is important to the outcome of the
study presented. Authors should also disclose conflict of interest with
products that compete with those mentioned in their manuscript.
Submission of Manuscripts
All manuscripts must be submitted through email on email@example.com or through scopemed system.
The submitted manuscripts that are not as per the Instructions to
Authors would be returned to the authors for technical correction,
before they undergo editorial/ peer-review. Generally, the manuscript
should be submitted in the form of two separate files:
 Title Page/First Page File/covering letter:
type of manuscript (original article, case report, review article,
Ethics Forum, Education Forum, Letter to editor, Images, etc.) title of
the manuscript, running title, names of all authors/ contributors (with
their highest academic degrees, designation and affiliations) and
name(s) of department(s) and/ or institution(s) to which the work should
be credited, All information which can reveal your identity should be
here. Use text/rtf/doc files. Do not zip the files.
total number of pages, total number of photographs and word counts
separately for abstract and for the text (excluding the references,
tables and abstract), word counts for introduction + discussion in case
of an original article;
c) Source(s) of support in the form of grants, equipment, drugs, or all of these;
if any. One or more statements should specify 1) contributions that
need acknowledging but do not justify authorship, such as general
support by a departmental chair; 2) acknowledgments of technical help;
and 3) acknowledgments of financial and material support, which should
specify the nature of the support. This should be included in the title
page of the manuscript and not in the main article file.
the manuscript was presented as part at a meeting, the organization,
place, and exact date on which it was read. A full statement to the
editor about all submissions and previous reports that might be regarded
as redundant publication of the same or very similar work. Any such
work should be referred to specifically, and referenced in the new
paper. Copies of such material should be included with the submitted
paper, to help the editor decide how to handle the matter.
f) Registration number in case of a clinical trial and where it is registered (name of the registry and its URL)
of Interest of each author/ contributor. A statement of financial or
other relationships that might lead to a conflict of interest, if that
information is not included in the manuscript itself or in an authors'
h) Criteria for inclusion in the authors/ contributors list
statement that the manuscript has been read and approved by all the
authors, that the requirements for authorship as stated earlier in this
document have been met, and that each author believes that the
manuscript represents honest work, if that information is not provided
in another form (see below); and
name, address, e-mail, and telephone number of the corresponding
author, who is responsible for communicating with the other authors
about revisions and final approval of the proofs, if that information is
not included on the manuscript itself.
manuscript must not contain any mention of the authors' names or
initials or the institution at which the study was done or
acknowledgements. Page headers/running title can include the title but
not the authors' names. Manuscripts not in compliance with The Journal's
blinding policy will be returned to the corresponding author. The main
text of the article, beginning from Abstract till References (including
tables) should be in this file. Use rtf/doc files. Do not zip the files.
Limit the file size to 1024 kb (1 MB). Do not incorporate images in the
file. The pages should be numbered consecutively, beginning with the
first page of the blinded article file.
good quality color images. Each image should be less than 4 MB in size.
Size of the image can be reduced by decreasing the actual height and
width of the images (keep up to 1800 x 1200 pixels or 5-6 inches).
Images can be submitted as jpeg files. Do not zip the files. Legends for
the figures/images should be included at the end of the article file.
National Journal of Medical Research
Preparation of Manuscripts
be prepared in accordance with "Uniform requirements for Manuscripts
submitted to Biomedical Journals" developed by the International
Committee of Medical Journal Editors (October 2006). The uniform
requirements and specific requirement of NJMR accepts manuscripts
written in American English.
Copies of any permission(s)
It is the
responsibility of authors/ contributors to obtain permissions for
reproducing any copyrighted material. A copy of the permission obtained
must accompany the manuscript. Copies of any and all published articles
or other manuscripts in preparation or submitted elsewhere that are
related to the manuscript must also accompany the manuscript. The
material should be sent to any of the two addresses given above.
include randomized controlled trials, intervention studies, studies of
screening and diagnostic test, outcome studies, cost effectiveness
analyses, case-control series, and surveys with high response rate. The
text of original articles amounting to up to 3000 words (excluding
Abstract, references and Tables) should be divided into sections with
the headings Abstract, Key-words, Introduction, Material and Methods,
Results, Discussion, References, Tables and Figure legends.
Introduction: State the purpose and summarize the rationale for the study or observation.
Materials and Methods: It should include and describe the following aspects:
Ethics: When reporting studies on human beings, indicate
whether the procedures followed were in accordance with the ethical
standards of the responsible committee on human experimentation
(institutional or regional) and with the Helsinki Declaration of 1975,
as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html
). For prospective studies involving human participants, authors are
expected to mention about approval of (regional/ national/ institutional
or independent Ethics Committee or Review Board, obtaining informed
consent from adult research participants and obtaining assent for
children aged over 7 years participating in the trial. The age beyond
which assent would be required could vary as per regional and/ or
national guidelines. Ensure confidentiality of subjects by desisting
from mentioning participants names, initials or hospital numbers,
especially in illustrative material. When reporting experiments on
animals, indicate whether the institutions or a national research
councils guide for, or any national law on the care and use of
laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both human as
well as animal studies) must be supplied by the authors on demand.
Animal experimental procedures should be as humane as possible and the
details of anesthetics and analgesics used should be clearly stated. The
ethical standards of experiments must be in accordance with the
guidelines provided by the CPCSEA and World Medical Association
Declaration of Helsinki on Ethical Principles for Medical Research
Involving Humans for studies involving experimental animals and human
beings, respectively). The journal will not consider any paper which is
ethically unacceptable. A statement on ethics committee permission and
ethical practices must be included in all research articles under the
Materials and Methods section.
Selection and Description of Participants:
Describe your selection of the observational or experimental
participants (patients or laboratory animals, including controls)
clearly, including eligibility and exclusion criteria and a description
of the source population. Reports of randomized clinical trials should
present information on all major study elements, including the protocol,
assignment of interventions (methods of randomization, concealment of
allocation to treatment groups), and the method of masking (blinding),
based on the CONSORT Statement ( http://www.consort-statement.org ).
Whenever possible quantify findings and present them with appropriate
indicators of measurement error or uncertainty (such as confidence
intervals). Authors should report losses to observation (such as,
dropouts from a clinical trial). When data are summarized in the Results
section, specify the statistical methods used to analyze them. Avoid
non-technical uses of technical terms in statistics, such as 'random'
(which implies a randomizing device), 'normal', 'significant',
'correlations', and 'sample'. Define statistical terms, abbreviations,
and most symbols. Specify the computer software used. Use upper italics
(Results: Present your results in a logical sequence in the text,
tables, and illustrations, giving the main or most important findings
first. Do not repeat in the text all the data in the tables or
illustrations; emphasize or summarize only important observations.
Extra- or supplementary materials and technical detail can be placed in
an appendix where it will be accessible but will not interrupt the flow
of the text; alternatively, it can be published only in the electronic
version of the journal.
When data are summarized in the Results section, give numeric results
not only as derivatives (for example, percentages) but also as the
absolute numbers from which the derivatives were calculated, and specify
the statistical methods used to analyze them. Restrict tables and
figures to those needed to explain the argument of the paper and to
assess its support. Use graphs as an alternative to tables with many
entries; do not duplicate data in graphs and tables. Where
scientifically appropriate, analyses of the data by variables such as
age and sex should be included.
Discussion: Include summary of key findings (primary outcome
measures, secondary outcome measures, results as they relate to a prior
hypothesis); Strengths and limitations of the study (study question,
study design, data collection, analysis and interpretation);
Interpretation and implications in the context of the totality of
evidence (is there a systematic review to refer to, if not, could one be
reasonably done here and now?, what this study adds to the available
evidence, effects on patient care and health policy, possible
mechanisms); Controversies raised by this study; and Future research
directions (for this particular research collaboration, underlying
mechanisms, clinical research). Do not repeat in detail data or other
material given in the Introduction or the Results section. In
particular, contributors should avoid making statements on economic
benefits and costs unless their manuscript includes economic data and
analyses. Avoid claiming priority and alluding to work that has not been
completed. New hypotheses may be stated if needed, however they should
be clearly labeled as such. About 30 references can be included. These
articles generally should not have more than six authors.
is expected that these articles would be written by individuals who
have done substantial work on the subject or are considered experts in
the field. A short summary of the work done by the contributor(s) in the
field of review should accompany the manuscript.
prescribed word count is up to 3000 words excluding tables, references
and abstract.The manuscript may have about 90 references. The manuscript
should have an unstructured Abstract (250 words) representing an
accurate summary of the article. The section titles would depend upon
the topic reviewed. Authors submitting review article should include a
section describing the methods used for locating, selecting, extracting,
and synthesizing data. These methods should also be summarized in the
journal expects the contributors to give post-publication updates on
the subject of review. The update should be brief, covering the advances
in the field after the publication of the article and should be sent as
a letter to editor, as and when major development occurs in the field.
interesting and rare cases can be reported. They should be unique,
describing a great diagnostic or therapeutic challenge and providing a
learning point for the readers. Cases with clinical significance or
implications will be given priority. These communications could be of up
to 1000 words (excluding Abstract and references) and should have the
following headings: Abstract (unstructured), Key-words, Introduction,
Case report, Discussion, Reference, Tables and Legends in that order.
manuscript could be of up to 1000 words (excluding references and
abstract) and could be supported with up to 10 references. Case Reports
could be authored by up to four authors
should be short and decisive observations. They should preferably be
related to articles previously published in the Journal or views
expressed in the journal. They should not be preliminary observations
that need a later paper for validation. The letter could have up to 500
words and 5 references. It could be generally authored by not more than
Editorial, Guest Editorial, and Commentary are solicited by the editorial board.
should be numbered consecutively in the order in which they are first
mentioned in the text (not in alphabetic order). Identify references in
text, tables, and legends by Arabic numerals in superscript with square
bracket after the punctuation marks. References cited only in tables or
figure legends should be numbered in accordance with the sequence
established by the first identification in the text of the particular
table or figure. Use the style of the examples below, which are based on
the formats used by the NLM in Index Medicus. The titles of journals
should be abbreviated according to the style used in Index Medicus. Use
complete name of the journal for non-indexed journals. Avoid using
abstracts as references. Information from manuscripts submitted but not
accepted should be cited in the text as "unpublished observations" with
written permission from the source. Avoid citing a "personal
communication" unless it provides essential information not available
from a public source, in which case the name of the person and date of
communication should be cited in parentheses in the text. The commonly
cited types of references are shown here, for other types of references
such as newspaper items please refer to ICMJE Guidelines ( http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.
a) Standard journal article (for up to six authors):
N, Husain N, Agarwal GG, Husain M. Utility of cysticercus fasciolaris
antigen in Dot ELISA for the diagnosis of neurocysticercosis. Indian J
Med Sci 2008;62:222-7.
Standard journal article (for more than six authors): List the first
six contributors followed by Nozari Y, Hashemlu A, Hatmi ZN, Sheikhvatan
M, Iravani A, Bazdar A, et al.
Volume with supplement: Shen HM, Zhang QF. Risk assessment of nickel
carcinogenicity and occupational lung cancer. Environ Health Perspect
1994; 102 Suppl 1:275-82.
d) Issue with supplement:
Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 1996; 23(1, Suppl 2):89-97.
Books and Other Monographs
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
b) Editor(s), compiler(s) as author:
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM,
editors. Hypertension: pathophysiology, diagnosis, and management. 2nd
ed. New York: Raven Press; 1995. pp. 465-78.
Electronic Sources as reference
Journal article on the Internet
Monograph on the Internet
KM, Gelband H, editors. Improving palliative care for cancer [monograph
on the Internet]. Washington: National Academy Press; 2001 [cited 2002
Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/ .
[homepage on the Internet]. New York: Association of Cancer Online
Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9].
Available from: http://www.cancer-pain.org/ .
Part of a homepage/Web site
Medical Association [homepage on the Internet]. Chicago: The
Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA
Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html
Prepation of tables & Illustration
Tables should be self-explanatory and should not duplicate textual material.
Tables with more than 10 columns and 25 rows are not acceptable.
Number tables, in Arabic numerals, consecutively in the order of their
first citation in the text and supply a brief title for each.
Place explanatory matter in footnotes, not in the heading.
Explain in footnotes all non-standard abbreviations that are used in each table.
Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
For footnotes use the following symbols, in this sequence: *, , , , ||, , **, ,
Tables with their legends should be provided at the end of the text
after the references. The tables along with their number should be cited
at the relevant place in the text
Figures should be numbered consecutively according to the order in which they have been first cited in the text.
numbers, and symbols should be clear and of uniform size. The lettering
for figures should be large enough to be legible after reduction to fit
the width of a printed column.
arrows, or letters used in photomicrographs should contrast with the
background and should be marked neatly with transfer type or by tissue
overlay and not by pen.
Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
When graphs, scatter-grams or histograms are submitted the numerical data on which they are based should also be supplied.
The photographs and figures should be trimmed to remove all the unwanted areas.
If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.
a figure has been published elsewhere, acknowledge the original source
and submit written permission from the copyright holder to reproduce the
material. A credit line should appear in the legend for such figures.
for illustrations: Type or print out legends (maximum 40 words,
excluding the credit line) for illustrations using double spacing, with
Arabic numerals corresponding to the illustrations. Final figures for
print production: Send sharp, glossy, un-mounted, color photographic
prints, with height of 4 inches and width of 6 inches at the time of
submitting the revised manuscript. Print outs of digital photographs are
not acceptable. If digital images are the only source of images, ensure
that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels
in TIFF format. Send the images on a CD. Each figure should have a label
pasted (avoid use of liquid gum for pasting) on its back indicating the
number of the figure, the running title, top of the figure and the
legends of the figure. Do not write the contributor/s' name/s. Do not
write on the back of figures, scratch, or mark them by using paper
The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.
Manuscript submission, processing and publication charges
Journal does not charge the authors or authors institutions for the
submission. However once the manuscript is accepted the corresponding
author will have to pay manuscript handling and printing charges which
will be according to the page length of the article.
Once the manuscript is accepted details of these charges will be communicated to the author along with aceeptance.
Signed by all contributors
Previous publication / presentations mentioned (if applicable)
Source of funding mentioned (if applicable)
Conflicts of interest disclosed
Last name and given name provided along with Middle name initials (where
Author for correspondence, with e-mail address provided
Number of contributors restricted as per the instructions
Identity not revealed in paper except title page (e.g. name of the institute in
Methods, citing previous study as 'our study', names on figure labels, name of institute in photographs, etc.)
Margins 2.5 cm from all four sides
Page numbers included at bottom
Title page contains all the desired information
Running title provided (not more than 50 characters)
Abstract page contains the full title of the manuscript
Abstract provided (structured abstract of 250 words for original articles,
unstructured abstracts of about 150 words for all other manuscripts excluding letters to the Editor)
Key words provided (three or more)
Introduction of 75-100 words
Headings in title case (not ALL CAPITALS) References according to the journal's instructions, punctuation marks checked
Send the article file without Track Changes
Uniformly American English
the full term for each abbreviation at its first use in the title,
abstract, keywords and text separately unless it is a standard unit of
measure. Numerals from 1 to 10 spelt out
Numerals at the beginning of the sentence spelt out
Check the manuscript for spelling, grammar and punctuation errors
If a brand name is cited, supply the manufacturer's name and address (city and state/country).
No repetition of data in tables and graphs and in text
Actual numbers from which graphs drawn, provided
Figures necessary and of good quality (colour)
Table and figure numbers in Arabic letters (not Roman)
Labels pasted on back of the photographs (no names written)
Figure legends provided (not more than 40 words)
Patients' privacy maintained (if not permission taken)
Credit note for borrowed figures/tables provided
Write the full term for each abbreviation used in the table as a footnote
(to be modified as applicable and one singed copy attached with the manuscript)
Manuscript Title: _____________________________________________________________
certify that I/we have participated sufficiently in contributing to the
intellectual content, concept and design of this work or the analysis
and interpretation of the data (when applicable), as well as writing of
the manuscript, to take public responsibility for it and have agreed to
have my/our name listed as a contributor.
I/we believe copyright;
the right to grant permission to republish the article in whole or in part, with or without fee;
the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and
the right to republish the work in a collection of articles in any other mechanical or electronic format.
We give the rights to the corresponding author to make necessary changes
as per the request of the journal, do the rest of the correspondence on
our behalf and he/she will act as the guarantor for the manuscript on
All persons who have made substantial contributions to the work reported
in the manuscript, but who are not contributors, are named in the
Acknowledgment and have given me/us their written permission to be
named. If I/we do not include an Acknowledgment that means I/we have not
received substantial contributions from non-contributors and no
contributor has been omitted.
Name Signature Date signed
1 --------------- --------------- ---------------
2 --------------- --------------- ---------------
3 --------------- --------------- ---------------
4 --------------- --------------- --------------- (up to 4 contributors for case report/ images/ review)
5 --------------- --------------- ---------------
6 --------------- --------------- --------------- (up to 6 contributors for original studies)